APA (7th ed.) Citation

Rabl, M., Zullo, L., Lewczuk, P., Kornhuber, J., Karikari, T. K., Blennow, K., . . . Popp, J. (2024). Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression. Alzheimer's Research & Therapy, 16(1), . https://doi.org/10.1186/s13195-024-01526-4

Chicago Style (17th ed.) Citation

Rabl, Miriam, et al. "Plasma Neurofilament Light, Glial Fibrillary Acid Protein, and Phosphorylated Tau 181 as Biomarkers for Neuropsychiatric Symptoms and Related Clinical Disease Progression." Alzheimer's Research & Therapy 16, no. 1 (2024). https://doi.org/10.1186/s13195-024-01526-4.

MLA (9th ed.) Citation

Rabl, Miriam, et al. "Plasma Neurofilament Light, Glial Fibrillary Acid Protein, and Phosphorylated Tau 181 as Biomarkers for Neuropsychiatric Symptoms and Related Clinical Disease Progression." Alzheimer's Research & Therapy, vol. 16, no. 1, 2024, https://doi.org/10.1186/s13195-024-01526-4.